Cripto1/CRIPTO Antibody

About the Target

TDGF1 is a target of interest in many antibody-based workflows. Cripto-1 (CRIPTO), also known as TDGF-1, is a glycosylphosphatidylinositol (GPI)-anchored cell membrane protein and the founding member of the EGF-CFC (epidermal growth factor-Cripto-1-FRL-1-Cryptic) family. Structurally, it features an N-terminal signal peptide, a modified EGF-like domain, a conserved cysteine-rich CFC motif, and a short hydrophobic C-terminus for GPI attachment, enabling membrane-bound and soluble forms. Depending on the literature source, TDGF1 may also be discussed as Cripto1/CRIPTO and CRIPTO-1.

Reported cellular context includes cellmembrane, membrane, and secreted, which can matter when signal is compared across treatments or changing cell states. Following TDGF1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

TDGF1 is commonly interpreted in the context of cancer, developmental biology, and stem cell biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cellmembrane, membrane, and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cellmembrane, membrane, and secreted across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
• state transitions between self-renewal, priming, and differentiation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for TDGF1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in TDGF1 reflect biology rather than handling. When interpreting TDGF1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep TDGF1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.